Lombard Odier Asset Management (Switzerland) Sa G1 Therapeutics, Inc. Transaction History

Lombard Odier Asset Management (Switzerland) Sa

$1.14 Billion
Q3 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$4.04 - $8.51 $2.19 Million - $4.61 Million	-542,183 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$7.6 - $11.02 $3.86 Million - $5.6 Million	-507,764 Reduced 48.36%	542,183 $4.12 Million
Q4 2021 Feb 14, 2022	BUY	$10.16 - $16.17 $902,289 - $1.44 Million	88,808 Added 9.24%	1,049,947 $10.7 Million
Q3 2021 Nov 12, 2021	BUY	$13.16 - $22.47 $1.92 Million - $3.28 Million	145,823 Added 17.89%	961,139 $12.9 Million
Q2 2021 Aug 13, 2021	BUY	$19.57 - $26.32 $4.18 Million - $5.63 Million	213,725 Added 35.53%	815,316 $17.9 Million
Q1 2021 May 17, 2021	BUY	$17.58 - $32.59 $10.6 Million - $19.6 Million	601,591 New	601,591 $14.5 Million

Others Institutions Holding GTHX

# of Institutions

Shares Held

3.55M

Call Options Held

11.7K

Put Options Held

View Full List

About G1 Therapeutics, Inc.

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

More about GTHX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Switzerland) Sa, based on Form 13F filings with the SEC.

News

Stay updated on Lombard Odier Asset Management (Switzerland) Sa with notifications on news.

Account